via MARKETWIRE

BioSyent Inc.today announced a voluntarily initiated a recall of all lots of the Ciprofloxacin Injection 2 mg/mL (Intravenous Infusion) as a precautionary measure. There are currently no reports in Canada of any adverse reactions or adverse events as a result of the administration of Ciprofloxacin Injection to a patient.

This product was manufactured by Claris Lifesciences Limited (“Claris”) and therefore the product will bear both the BioSyent Pharma Inc. and Claris Lifesciences Limited names on the product and packaging.

This precautionary recall is being undertaken due to complaints in the United States on certain other medications manufactured by Claris which have subsequently been recalled. Claris has voluntarily extended this recall to include Ciprofloxacin Injection in the United States.